Literature DB >> 4064452

Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs.

M R Holdiness.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 4064452     DOI： 10.2165/00003088-198510060-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  15 in total

1.  Ethionamide: its passage into the cerebrospinal fluid in man.

Authors:  I E HUGHES; H SMITH
Journal:  Lancet       Date:  1962-03-24       Impact factor: 79.321

2.  Distribution and excretion of radioactive isoniazid in tuberculous patients.

Authors:  W R BARCLAY; R H EBERT; G V LE ROY; R W MANTHEI; L J ROTH
Journal:  J Am Med Assoc       Date:  1953-04-18

3.  Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis.

Authors:  J E Sippel; I A Mikhail; N I Girgis; H H Youssef
Journal:  Am Rev Respir Dis       Date:  1974-05

4.  Ethambutol in tuberculous meningitis.

Authors:  I D Bobrowitz
Journal:  Chest       Date:  1972-06       Impact factor: 9.410

5.  Some observations on dosage and toxicity of kanamycin in premature and full-term infants.

Authors:  H F Eichenwald
Journal:  Ann N Y Acad Sci       Date:  1966-06-14       Impact factor: 5.691

6.  Ethambutol in tuberculous meningitis.

Authors:  V A Place; M M Pyle; J De la Huerga
Journal:  Am Rev Respir Dis       Date:  1969-05

Review 7.  Antituberculous drugs.

Authors:  T T Yoshikawa; N K Fujita
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

Review 8.  Metabolism and pharmacokinetics of the antibiotic rifampin.

Authors:  M T Kenny; B Strates
Journal:  Drug Metab Rev       Date:  1981       Impact factor: 4.518

9.  The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man.

Authors:  D F ELMENDORF; W U CAWTHON; C MUSCHENHEIM; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1952-04
View more
  10 in total

1.  Drug-resistant tuberculosis: what are the treatment options?

Authors:  Amr S Albanna; Dick Menzies
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

Review 2.  Transplacental pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 3.  Management of tuberculosis meningitis.

Authors:  M R Holdiness
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 4.  Neurological manifestations and toxicities of the antituberculosis drugs. A review.

Authors:  M R Holdiness
Journal:  Med Toxicol       Date:  1987 Jan-Feb

Review 5.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

6.  The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis.

Authors:  P Phuapradit; K Supmonchai; S Kaojarern; C Mokkhavesa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

7.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

Review 8.  Clinical pharmacokinetics of clofazimine. A review.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

9.  Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management.

Authors:  Rajendra Prasad; Nikhil Gupta; Amitabh Banka
Journal:  Lung India       Date:  2018 Jan-Feb

10.  Detectable prednisolone is delayed in pericardial fluid, compared with plasma of patients with tuberculous pericarditis: A pilot study.

Authors:  Justin Shenje; Tawanda Gumbo; Lubbe Wiesner; Mpiko Ntsekhe; Bongani Mayosi; Ian Ross
Journal:  Int J Cardiol Heart Vasc       Date:  2019-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.